|
CDKN2AIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49210000022215E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.84109999760096E-08 |
| Normal-vs-Stage2 |
1.646670E-04 |
| Normal-vs-Stage3 |
1.7889299999907E-05 |
| Normal-vs-Stage4 |
1.035150E-03 |
| Stage1-vs-Stage2 |
2.175800E-01 |
| Stage1-vs-Stage3 |
3.738600E-01 |
| Stage1-vs-Stage4 |
7.976600E-01 |
| Stage2-vs-Stage3 |
7.372000E-01 |
| Stage2-vs-Stage4 |
5.922600E-01 |
| Stage3-vs-Stage4 |
7.919400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25260000038985E-07 |
| Normal-vs-AfricanAmerican |
6.77700000006887E-07 |
| Normal-vs-Asian |
3.040100E-03 |
| Caucasian-vs-AfricanAmerican |
4.728200E-01 |
| Caucasian-vs-Asian |
5.992200E-01 |
| AfricanAmerican-vs-Asian |
4.125000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.39690000467274E-08 |
| Normal-vs-Female |
1.58350000001306E-07 |
| Male-vs-Female |
2.510000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.13820000383569E-08 |
| Normal-vs-Extreme_Weight |
8.05540000259342E-08 |
| Normal-vs-Obese |
2.78580000179218E-08 |
| Normal-vs-Extreme_Obese |
2.590500E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.119200E-01 |
| Normal_Weight-vs-Obese |
1.761620E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.873400E-01 |
| Extreme_Weight-vs-Obese |
2.421600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.203400E-01 |
| Obese-vs-Extreme_Obese |
4.160800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.383600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.88139999982518E-07 |
| Normal-vs-Age(61-80Yrs) |
3.41670000070238E-08 |
| Normal-vs-Age(81-100Yrs) |
6.41799999999693E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.901200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.972100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.300200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.486300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.909400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.674200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.20539999987268E-07 |
| Normal-VS-Type2 PRCC |
5.55729995355136E-09 |
| Normal-VS-KIRP CIMP |
8.645600E-02 |
| Normal-VS-Unclassified PRCC |
3.12130000001964E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.262700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.754000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.288600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.474400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.486500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.264990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10689998780822E-09 |
| Normal-vs-N1 |
1.076450E-03 |
| Normal-vs-N2 |
1.276340E-02 |
| N0-vs-N1 |
1.824270E-02 |
| N0-vs-N2 |
8.690200E-01 |
| N1-vs-N2 |
3.571000E-01 |
|
|
